Craneware’s (CRW) Buy Rating Reiterated at Shore Capital

Shore Capital reaffirmed their buy rating on shares of Craneware (LON:CRW) in a research note released on Tuesday, Marketbeat Ratings reports. Shore Capital currently has a GBX 2,850 price target on the stock.

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 2,900 price target on shares of Craneware in a research report on Tuesday. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Craneware has a consensus rating of “Buy” and an average price target of GBX 2,873.67.

Craneware Stock Down 0.3%

Shares of LON CRW opened at GBX 1,790 on Tuesday. The stock has a market capitalization of £635.61 million, a PE ratio of 32.43 and a beta of 0.28. The company has a quick ratio of 1.00, a current ratio of 0.63 and a debt-to-equity ratio of 12.22. The firm has a fifty day moving average of GBX 1,976.39 and a 200-day moving average of GBX 2,179.97. Craneware has a 52-week low of GBX 1,330 and a 52-week high of GBX 2,644.

Craneware Company Profile

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.